Coronary artery bypass graft surgery and percutaneous coronary intervention are the treatment options in patients with ischemia and multivessel coronary artery disease (CAD). Comparisons of ...

A LARGE multinational study has revealed that patients with diabetes mellitus (DM) face significantly worse long-term outcomes following percutaneous coronary intervention (PCI) for coronary ...

Implantation of drug-eluting stents (DESs) remains central to percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) and chronic coronary syndromes (CCS). DES platforms, polymers ...

163.com Objectives The purpose of this study was to investigate whether fractional flow reserve (FFR) should be performed for patients with coronary artery disease (CAD) to guide the percutaneous ...

The present study aims to address the limitations of existing research in this field by developing and validating a clinical prognostic model tailored to predicting the 1-year risk of major adverse ...

Limited data exist on noncardiac surgery patients with prior percutaneous coronary intervention (PCI) in the contemporary era. The objective was to examine rate, characteristics, and outcomes of ...

Elixir Medical is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping ...

Historically, due to low procedural success rate, apparent inefficient resource utilization, potential increase in complication rates and uncertain clinical benefits, only about 10–20% of patients ...

De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary ...

Background: Coronary artery disease is a global health concern that necessitates treatments, such as percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Recent advancements in ...